Coronavirus Lockdowns At What Price And At Whose Cost?
29/7/20: COVID19 Update: Russia and BRIICS
Setback in COVID-19 effort as Roche’s Actemra fails in key trial
After Big Pharma abandoned infectious diseases, 5 biotech contrarians decided to go all in. Then Covid-19 changed everything
Population genetic screening shown to efficiently identify increased risk for inherited disease
How Global Capitalism Boosted Immunities
These German Military Dogs Have Been Trained To Sniff Out Coronavirus, Researchers Say
Wells Fargo: These 3 'Strong Buy' Stocks Are Must-Watch Names
New CCC19 data offer insights on COVID treatments for people with cancer
How Canada compares to other countries on COVID-19 cases and deaths
Covid Mortality Rates by Country
Scientists publish findings from 1st statewide COVID-19 random sample study in US
Why vaccines are less effective in the elderly, and what it means for COVID-19
New diagnostic test for heart failure patients could also help COVID-19 patients
BeiGene, Assembly Bio Ink $540M China HBV Deal; Shares Surge In Pre-Market
17/7/20: COVID19 Update: USA vs EU27
The Media's Jihad Against Sweden's No-Lockdown Policy Ignores Key Facts
Charts of the Week: Tracking deaths of despair; the pandemic’s economic damage; uneven PPP distribution in metros
28 Million More Americans Could Wind Up Homeless Due To The COVID-19 Pandemic
Penn researchers find three distinct immune responses for sicker COVID-19 patients
Common FDA-approved drug may effectively neutralize virus that causes COVID-19
How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer
New Approach May Dramatically Improve Damaged Lungs to be Used for Transplants
The Dangers Of Keeping The Schools Closed
COVID-19 may attack patients’ central nervous system
Indigenous communities at increased risk during the coronavirus pandemic
Equillium (EQ) Stock Price Target Gets a Big Boost; Here's What You Need to Know
Big data analytics enables scientists to model COVID-19 spread
Aldeyra Spikes 10% In Pre-Market On New Perceptive Stake
Abbott Labs, Edwards Lifesciences Settle Heart Device Patent Disputes